RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Summary

The purpose of the study was to test a null hypothesis that a combined modality treatment of esophageal cancer with neoadjuvant chemotherapy or chemoradiotherapy is equivalent to surgery alone and what are the benefits from adding irradiation to chemotherapy in neoadjuvant treatment of esophageal cancer.

Timeline

Start

2001-12

Primary completion

—

Completion

2004-04

Outcome

Outcome not reported

Stopped (Enrollment): “difficulty in recruitment”

Drugs

Indications